ABOUT US

Lentistem® Biotech is an R&D centred medical biotechnology company which designs and produces therapeutic lentiviral vectors. Our MISSION is to develop new technologies to improve the efficacy and safety of cancer immunotherapy (CAR-T cells). Our team is working in collaboration with several hospitals, academic labs and government agencies in Spain to create cost-effective and precise advanced gene-based therapies. We also offer our expertise in lentiviral-based gene delivery systems to provide cutting-edge tools for basic research. The company has exclusive license to multiple technologies, which are currently being used in 18 labs worldwide and cited in more than 70 peer-reviewed scientific publications.

We have state-of-art facilities for molecular analysis, cell biology small animal research and cell-culture facilities with P2-level safety standards to produce the highest grade viral vectors.

OUR TEAM

Miguel García Toscano

(PhD, MBA)

Expert in Biotechnology and International Business

Verónica Ayllón Cases

(PhD)

Expert in Blood Tumors

Juan Antonio Marchal

(Full Professor)

Expert in Solid Tumors, Biotechnology and R&D Companies

Houria Boulaiz

(Full Professor)

Expert in Lentiviral Vectors

Vaibah Bhatia

(PhD)

Expert in Biotechnology and International Business

Juan José Díaz Mochón

(PhD)

Expert in Nanotechnology and International Business

Pablo Galindo

(Full Professor)

Expert in Cell Therapy